Once the assay was confirmed, we screened DR6 serum protein levels from a panel healthy donor controls and a panel of patients with different tumor types including bladder cancer, hepatic cancer, pancreatic cancer, mullerian carcinosarcomas, and adult sarcomas. The gene discussed is TNFRSF21; the disease is carcinosarcoma.